β2-Adrenergic receptor activation on donor cells ameliorates acute GvHD
Hemn Mohammadpour(Roswell Park Comprehensive Cancer Center), Philip L. McCarthy(Roswell Park Comprehensive Cancer Center)
Cited by 18
Related Papers
Lenalidomide after Stem-Cell Transplantation for Multiple Myeloma
|New England Journal of Medicine|2012|1.1k
Triplet Therapy, Transplantation, and Maintenance until Progression in Myeloma
|New England Journal of Medicine|2022|457
Increasing Incidence of Chronic Graft-versus-Host Disease in Allogeneic Transplantation: A Report from the Center for International Blood and Marrow Transplant Research
|Biology of Blood and Marrow Transplantation|2014|435
Increasing use of allogeneic hematopoietic cell transplantation in patients aged 70 years and older in the United States
|Blood|2017|296
Metabolic Syndrome and Cardiovascular Disease after Hematopoietic Cell Transplantation: Screening and Preventive Practice Recommendations from the CIBMTR and EBMT
|Biology of Blood and Marrow Transplantation|2016|64